The dose your doctor recommends may be based on the following: other medical conditions you have other medications you are taking how you respond to this medication your weight your height The recommended dose of Qsymia is based on body mass index, which is calculated using a patient’s height...
Start treatment with Qsymia 3.75 mg/23 mg (phentermine 3.75 mg/topiramate 23 mg extended-release) daily for 14 days; after 14 days increase to the recommended dose of Qsymia 7.5 mg/46 mg (phentermine 7.5 mg/topiramate 46 mg extended-release) once daily. Weight loss should be evaluated 12 ...
Your patients’ results may vary depending on their weight, BMI, diet, activity level, dose of Qsymia, and other factors. The titration schedule for the studies was faster than what is recommended in the Qsymia package insert. Subjects took the 3.75 mg/23 mg strength for one week, then ...
Patients paying cash or if Qsymia is not covered by commercial insurance, can receive $70 off 3.75 mg/23 mg dose quantities of 14-15 days and $80 off all other doses with quantities of 28-30 days. Please note that quantity claims of 16-27 days are not eligible for the Qsymia Savings...
Your healthcare provider may change your child’s dose of Qsymia or stop treatment if they are not growing as expected. Metabolic Acidosis. Qsymia can cause a condition called metabolic acidosis. This happens when there is too much acid in the blood. If this condition is not treated, it ...
It will be available in a standard dose, but also a higher dose for select patients. Women using Qsymia must consistently use an effective method of birth control. If a woman becomes pregnant while using Qsymia, they should discontinue the medication immediately and contact their physician. Who ...
If a patient gets anxious or palpitations from things like coffee or caffeine, or feels like they are speeding if they take a decongestant or an energy drink, they may have those same side effects from phentermine. These side effects can be reduced by splitting the dose, half in the morning...
percent of their body weight by the twelfth week of treatment were not likely to achieve weight loss with continued treatment, and may need a higher dose. If those patients don't lose at least 5 percent of their weight after 12 weeks on the higher dose, they should stop taking the drug...
Long-term glycaemic effects of weight loss with low-dose, controlled-release phentermine/topiramate (PHEN/TPM CR) in overweight/obese subjects with diabetes. 47th Annual Meeting of the European Association for the Study of Diabetes.: abstr. 906, 12 Sep 2011 Allison DB, Gadde KM, Garvey WT,...